Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Journal of Arthroplasty|June 20, 2018
The Effects of Revision Total Hip Arthroplasty on Medicare Spending and Beneficiary Outcomes: Implications for the Comprehensive Care for Joint Replacement ModelLane Koenig, Chaoling Feng, Fang He, et al.
International Journal of Environmental Research and Public Health|February 18, 2017
Associations between Obesity and Spinal Diseases: A Medical Expenditure Panel Study AnalysisBinwu Sheng, Chaoling Feng, Donglan Zhang, et al.
Health Equity|August 24, 2019
Association Between Prior Insurance and Health Service Utilization Among the Long-Term Uninsured in South CarolinaLu Shi, Ellen C Francis, Chaoling Feng, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|October 4, 2017
Does Awareness of the Affordable Care Act Reduce Adverse Selection? A Study of the Long-term Uninsured in South CarolinaLu Shi, Chaoling Feng, Sarah Griffin, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 26, 2019
Length of stay, mortality, and readmissions among Medicare cancer patients treated with glucarpidase and conventional care: a retrospective studyBerna Demiralp, Lane Koenig, Jaya Kala, et al.
Leukemia & Lymphoma|April 3, 2024
Hospital healthcare resource utilization and costs for chimeric antigen T-cell therapy and autologous hematopoietic cell transplant in patients with large B-cell lymphoma in the United StatesChendi Cui, Chaoling Feng, Ning Rosenthal, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|June 6, 2023
Health resource utilization and costs of care for adult patients with relapsed or refractory mantle cell lymphoma in the United States: a retrospective claims analysisDiane Ito, Chaoling Feng, Christine Fu, et al.
Journal of Medical Economics|April 21, 2022
Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the USOlalekan O Oluwole, Rongzhe Liu, Ibrahim Diakite, et al.
Clinical Therapeutics|November 19, 2023
Health Care Resource Utilization and Total Costs of Care for Adult Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia in the United States: A Retrospective Claims AnalysisDiane Ito, Chaoling Feng, Christine Fu, et al.
Journal of Medical Economics|December 6, 2023
An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United StatesOlalekan O Oluwole, Anik R Patel, Sachin Vadgama, et al.
Pageof 2